THE USE OF WEIGHT LOSS DRUGS AND MUSCLE LOSS
THE USE OF WEIGHT LOSS DRUGS AND MUSCLE LOSS An editorial in The Lancet highlights the critical importance of muscle mass with weight loss medications. . A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These medications, celebrated for their effectiveness in treating obesity, have raised concerns regarding the potential for substantial muscle loss as part of the weight loss process. Dr. Steven Heymsfield, professor of metabolism and body composition, and Dr. M. Cristina Gonzalez, adjunct and visiting professor of metabolism-body composition, both of Pennington Biomedical Research Center, joined colleagues Dr. Carla Prado of the University of Alberta and Dr. Stuart Phillips of McMaster University in authoring The Lancet commentary, "Muscle Matters: The Effects of Medically Induced W...